Cell based therapies are a growing interest in all areas of medicine as they are viewed as long term solutions rather than temporary fixes. A recent journal article highlights progress made in better understanding the potential for two basic types of adult stem cells.
The first-of-a-kind award provides $200,000 for use in innovative research on lupus, an unpredictable and sometimes fatal autoimmune disease that affects an estimated 1.5 million Americans.
An open dialogue between physicians and patients is critical to ensuring patients receive the best care and treatment possible.
The Lupus Foundation of America strongly supports the Patients’ Access to Treatment Act (H.R. 460).
Learn what makes lupus so different from many other diseases and why lupus is a cruel mystery.